Combination therapy with saxagliptin and vitamin d for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial

HIGHLIGHTS

• who: Xiang Yan from the The ADVENT (Adding , inhibitor and vitamin D for adultonset autoimmune diabetes) study is a prospective, multi-centre, open-label, randomized controlled trial, comprising a, week runin period and then, month treatment periodThe trial was conducted from September , to December , at , sites across , provinces and , province-level municipalities in China in accordance with the principles of the Declaration of Helsinki, and the International Conference on Harmonisation guidelines for Good Clinical Practice. Ethical committee approval was obtained at the Ethics Committee of the Second Xiangya Hospital, Central South University and each participating site. All . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.